Home › Funds › RA CAPITAL MANAGEMENT, L.P. › NTLA
RA CAPITAL MANAGEMENT, L.P. position in NTLA
INTELLIA THERAPEUTICS INC · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 4,526,926 shares of NTLA (INTELLIA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$76.6M, representing 0.67% of its reported portfolio and ranking #30 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s NTLA position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in NTLA in Q2 2026 at 4,526,926 shares (US$76.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 4.53M | $76.60M | New |
About NTLA and 13F data
NTLA (INTELLIA THERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in NTLA — the largest reported positions include ARK Invest (US$285.5M), REGENERON PHARMACEUTICALS, INC. (US$62.7M), Amova Asset Management Americas, Inc. (US$49.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NTLA
- ARK Invest 16.88M sh · $285.54M · Q2 2026
- REGENERON PHARMACEUTICALS, INC. 3.70M sh · $62.65M · Q2 2026
- Amova Asset Management Americas, Inc. 2.90M sh · $49.03M · Q2 2026
- Contrarius Group Holdings Ltd 1.96M sh · $33.08M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.50M sh · $25.38M · Q2 2026
- Ghisallo Capital Management LLC 1.20M sh · $20.30M · Q2 2026
- IQ EQ FUND MANAGEMENT (IRELAND) Ltd 777.95K sh · $13.16M · Q2 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held NTLA?
RA CAPITAL MANAGEMENT, L.P. has disclosed NTLA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in NTLA?
As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 4.53M shares of NTLA (INTELLIA THERAPEUTICS INC), valued at $76.60M, representing 0.67% of its reported portfolio and ranking #30.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling NTLA?
In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. newly opened its position in NTLA.
Which other funds hold NTLA?
Other major institutional holders of NTLA include ARK Invest, REGENERON PHARMACEUTICALS, INC., Amova Asset Management Americas, Inc., among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.